Related Experiment Video
Updated: May 29, 2026
07:53
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
Published on: April 26, 2016
Berberine hydrochloride: anticancer activity and nanoparticulate delivery system
Wen Tan1, Yingbo Li, Meiwan Chen
1State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao Special Administrative Region, China.
International Journal of Nanomedicine
|September 21, 2011
Summary
Berberine hydrochloride shows promise for cancer therapy, especially when delivered via nanoparticulate systems that improve its bioavailability and anticancer efficacy. Further research into its metabolic regulation mechanisms could enhance cancer treatment strategies.
Area of Science:
- Pharmacology and Traditional Chinese Medicine
- Nanotechnology in Drug Delivery
- Cancer Metabolism Research
Background:
- Berberine hydrochloride, a traditional Chinese medicine component, possesses diverse pharmacological effects but suffers from poor solubility, stability, and bioavailability.
- Recent advancements in pharmaceutical preparations, particularly nanoparticulate delivery systems, have significantly improved its clinical application prospects.
- Emerging research highlights its potential in regulating cancer cell metabolism, offering new therapeutic avenues.
Purpose of the Study:
- To review the progress in understanding berberine hydrochloride's anticancer mechanisms.
- To highlight the role of nanoparticulate delivery systems in overcoming berberine hydrochloride's limitations.
- To explore the potential of berberine hydrochloride in reprogramming cancer cell metabolism.
Main Methods:
- Literature search of conventional databases (PubMed, Scopus, Web of Science).
- Keywords used: "berberine hydrochloride", "anti-cancer mechanism", "nanoparticulate delivery system".
- Synthesis of research findings on berberine hydrochloride and its delivery systems.
Main Results:
- Nanoparticulate delivery systems enhance berberine hydrochloride's bioavailability and therapeutic potential.
- Berberine hydrochloride demonstrates significant anticancer activity by regulating cancer cell metabolism.
- Research indicates a need to further explore metabolic reprogramming strategies using these systems.
Conclusions:
- Berberine hydrochloride is poised to become a key component in nanoparticulate delivery systems for cancer therapy.
- Its known mechanisms, including overcoming multidrug resistance and enhancing chemotherapy sensitivity, offer new insights.
- Optimized pharmaceutical procedures for nanoparticulate berberine hydrochloride could significantly improve cancer treatment and patient quality of life.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...